Nicolas Hoertel1,2,3,4, Julien Sabatier2, Carlos Blanco5, Mark Olfson6, Jean-Pierre Schuster7, Guillaume Airagnes2,3,8,9, Hugo Peyre10,11, Frédéric Limosin2,3,4. 1. Department of Psychiatry, Corentin Celton Hospital, Paris Descartes University, 4 parvis Corentin Celton; 92130 Issy-les-Moulineaux, France. nico.hoertel@yahoo.fr. 2. Regional Resource Center for Old Age Psychiatry (CRRPSA), Medical and University Department of Psychiatry and Addictions, APHP Center-Paris University, Paris, France. 3. Paris Descartes Faculty of Medicine, Paris University, Paris, France. 4. INSERM U1266, Institute of Psychiatry and Neuroscience of Paris, Paris, France. 5. Division of Epidemiology, Services, and Prevention Research, National Institute on Drug Abuse, Bethesda, Maryland, USA. 6. Department of Psychiatry, New York State Psychiatric Institute/Columbia University, New York, New York, USA. 7. Old-age psychiatry service, Lausanne University Hospital, Lausanne, Switzerland. 8. UMS 011, Population-based Epidemiological Cohorts, Inserm, Villejuif, France. 9. UMR 1168, VIMA, Inserm, Villejuif, France. 10. Assistance Publique-Hôpitaux de Paris, Robert Debré Hospital, Child and Adolescent Psychiatry Department, Paris, France. 11. Cognitive Sciences and Psycholinguistic Laboratory, Ecole Normale Supérieure, Paris, France.
Authors: Jean-Pierre Schuster; Marie-Pierre F Strippoli; Nicolas Hoertel; Pedro Marques-Vidal; Caroline L Vandeleur; Frédéric Limosin; Martin Preisig; Armin von Gunten Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2021-11-29 Impact factor: 4.328